# EPAM Systems (EPAM) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/EPAM
## Company Profile
- Ticker: EPAM
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 109.95 USD
- Market cap: 5393194676.7300005 USD
- Last updated: 2026-10-05
## Business Overview
### Digital and AI Transformation Company
EPAM Systems provides software engineering, product development, consulting, and digital-transformation services. It serves large enterprises and growth companies that need to modernize technology platforms, build digital products, and adopt artificial intelligence.
### Engineering-Led Delivery Model
EPAM's core capabilities include custom software, platform engineering, cloud modernization, DevOps, quality engineering, and physical-product development. The company differentiates itself through deep technical delivery rather than relying only on strategy consulting.
### AI, Data, and Cloud Services
The company helps clients implement data platforms, generative AI, AI-native engineering, analytics, and cloud architecture. Its work includes model integration, responsible AI controls, cybersecurity, and redesigning software-development processes around AI tools.
### Consulting and Experience Design
EPAM combines engineering with business consulting, product strategy, customer-experience design, and organizational transformation. This enables the company to move from advisory work into implementation and long-term platform operation.
### Global Industry Coverage
EPAM serves financial services, consumer, healthcare and life sciences, software and technology, telecommunications, industrial, automotive, energy, and other sectors. Its distributed delivery organization provides global engineering capacity with local client engagement.
## Why The Stock Is Moving

As of Oct 5, 2026, EPAM closed up 1.53% at $109.95. No new same-company headline was identified in the current news window.

## Recent News
- 2018-07-10 20:05 EST — [EPAM Announces Date for Second Quarter 2018 Earnings Release and Conference Call](https://biopharmsignal.com/news/EPAM/epam-announces-date-for-second-quarter-2018-earnings-release-and-conference-call-00cefe87) — Source: EPAM Systems
- 2018-06-25 14:57 EST — [EPAM’s InfoNgen™ Debuts With Highest Score Possible in Seven Criteria in AI-Based Text Analytics Platforms Report by Independent Research Firm](https://biopharmsignal.com/news/EPAM/epam-s-infongen-debuts-with-highest-score-possible-in-seven-criteria-in-ai-based-0bc447f1) — Source: EPAM Systems
- 2018-05-31 14:00 EST — [Alexion SmartPanel Developed in Partnership With EPAM Wins Judges’ Prize in the 2018 Bio-IT World Best Practices Awards](https://biopharmsignal.com/news/EPAM/alexion-smartpanel-developed-in-partnership-with-epam-wins-judges-prize-in-the-2-ebc2876c) — Source: EPAM Systems
- 2018-05-21 14:00 EST — [Hotels.com App Wins 2018 MediaPost Appy Award in Travel & Tourism Category](https://biopharmsignal.com/news/EPAM/hotels-com-app-wins-2018-mediapost-appy-award-in-travel-tourism-category-ea5ec5a4) — Source: EPAM Systems
- 2018-05-09 10:00 EST — [EPAM Reports Results for First Quarter 2018](https://biopharmsignal.com/news/EPAM/epam-reports-results-for-first-quarter-2018-dcf5f968) — Source: EPAM Systems